Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22389361 | 0.87 | GAA (0.33) | SRC | |
| SCHEMBL20904541 | 0.84 | SRC (0.31) | SRC | |
| SCHEMBL4567536 | 0.81 | SRC (0.35) | SRCTRPV1 | |
| SCHEMBL20904510 | 0.81 | SRC (0.36) | SRCCA12CA1CA2CA9 | |
| SCHEMBL20904409 | 0.78 | SRC (0.35) | SRC | |
| SCHEMBL22341667 | 0.77 | SRC (0.38) | SRCCA12CA1CA2CA9 | |
| SCHEMBL20898042 | 0.75 | SRC (0.38) | SRCCA12CA1CA2CA9 | |
| SCHEMBL25590825 | 0.75 | SRC (0.35) | SRCTRPV1 | |
| SCHEMBL20898356 | 0.74 | SRC (0.40) | SRCCA12CA1CA2CA9 | |
| SCHEMBL20898588 | 0.74 | SRC (0.36) | SRCCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200276102-A1 | SPECIFIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINES, METHOD, AND COMPOSITION | L'OREAL (FR) | 2020-09-03 | — | — | US | disclosed |
| WO-2019072697-A1 | SPECIFIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINES, METHOD, AND COMPOSITION | L'OREAL (FR) | 2019-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200276102-A1 | SPECIFIC 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINES, METHOD, AND COMPOSITION | KRT18, TUBA1C, TPM4 | SRC 2302/4885TRPV1 923/4885CA12 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.